Cannabidiol (CBD) Inhibits Foam Cell Formation via Regulating Cholesterol Homeostasis and Lipid Metabolism
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202400154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Mengxue He und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Technology, School of Food Science and Technology, National Engineering Research Center for Functional Food,…. Hauptthemen laut MEDLINE: Foam Cells, Cannabidiol, Cholesterol, ATP Binding Cassette Transporter 1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Postdoctoral Fellowship Program of CPSF, Open Project Program of State Key Laboratory of Food Science and Technology, Jiangnan University.
Abstract (Originalsprache)
Scope The cannabidiol (CBD) in hemp oil has important pharmacological activities. Accumulating evidence suggests that CBD is beneficial in the cardiovascular system and has been applied as a health supplement for atherosclerosis. However, the mechanism remains unclear. Methods and results This study investigates the impact of CBD on foam cell formation, cholesterol homeostasis, and lipid metabolism in macrophages. CBD elevates the levels of peroxisome proliferator‐activated receptor gamma (PPARγ) and its associated targets, such as ATP binding transporter A1/G1 (ABCA1/ABCG1), thus reducing foam cell formation, and increasing cholesterol efflux within macrophages. Notably, the upregulation of ABCA1 and ABCG1 expression induced by CBD is found to be attenuated by both a PPARγ inhibitor and PPARγ small interfering RNA (siRNA). Moreover, transfection of PPARγ siRNA results in a decrease in the inhibitory effect of CBD on foam cell formation and promotion of cholesterol efflux. Through lipidomics analysis, the study finds that CBD significantly reverses the enhancement of ceramide (Cer). Correlation analysis indicates a negative association between Cer level and the expression of ABCA1/ABCG1. Conclusion This study confirms that CBD can be an effective therapeutic candidate for atherosclerosis treatment by activating PPARγ, up‐regulating ABCA1/ABCG1 expression, and down‐regulating Cer level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Technology, School of Food Science and Technology, National Engineering Research Center for Functional Food, National Engineering Laboratory for Cereal Fermentation Technology, C…
ORCID-Profile: Yong-Jiang Xu, Yuanfa Liu
Förderung
- Postdoctoral Fellowship Program of CPSF
- Open Project Program of State Key Laboratory of Food Science and Technology, Jiangnan University
Zitieren
APA
He, M., Shi, J., Xu, Y. J., & Liu, Y. (2024). Cannabidiol (CBD) Inhibits Foam Cell Formation via Regulating Cholesterol Homeostasis and Lipid Metabolism. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202400154
Vancouver
He M, Shi J, Xu YJ, Liu Y. Cannabidiol (CBD) Inhibits Foam Cell Formation via Regulating Cholesterol Homeostasis and Lipid Metabolism. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202400154
BibTeX
@article{He2024,
author = {He, Mengxue and Shi, Jiachen and Xu, Yong-Jiang and Liu, Yuanfa},
title = {Cannabidiol (CBD) Inhibits Foam Cell Formation via Regulating Cholesterol Homeostasis and Lipid Metabolism},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202400154}
}
EUVIMED